Premium
Decision making in pediatric hematopoietic cell transplantation: Influential factors vary among diseases
Author(s) -
Schulz Ginny L.,
Kelly Katherine P.,
Holtmann Megan,
Doering Michelle M.,
Armer Jane M.
Publication year - 2018
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.26890
Subject(s) - medicine , hematopoietic cell , perspective (graphical) , transplantation , qualitative research , hematopoietic stem cell transplantation , warrant , pediatric oncology , identification (biology) , family medicine , intensive care medicine , haematopoiesis , stem cell , cancer , social science , genetics , botany , artificial intelligence , sociology , computer science , financial economics , economics , biology
Hematopoietic cell transplantation (HCT) is not a trivial treatment decision in pediatrics. We sought to understand what influences this decision‐making process from the perspectives of the pediatric patients, their family, and physicians. Using integrative review methods, we identified 19 relevant studies: six qualitative, ten quantitative, and three mixed methods. Synthesis of the results revealed six themes describing patient, family, and provider decision‐making processes with distinct subthemes contrasting influential factors among malignant and nonmalignant diseases. Identification of what influences HCT decision making will aid in development of decision support, education, and communication strategies. The child/adolescent voice and provider perspective warrant more attention.